Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 to the history and removed Revision: v3.4.2 from the history.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedVersion 86 (2026-02-13) adds Contacts/Locations and Study Status to the record history, and the 2026-02-02 entry was removed.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the page history. Removed the funding-lapse notice and the prior Revision: v3.4.1 banner.SummaryDifference0.3%

- Check41 days agoChange DetectedContacts/Locations and Study Status have been added, providing current trial locations and status details. A site-wide government funding notice has also been added, and the previous revision v3.4.0 was deleted.SummaryDifference0.5%

- Check48 days agoChange DetectedThe glossary visibility was added and color-coded change indicators were described; the No FEAR Act Data label and revision tag were updated from v3.3.4 to v3.4.0.SummaryDifference0.4%

- Check62 days agoChange DetectedRevision: v3.3.4 was added to the page history, replacing the previous v3.3.3. This is a minor maintenance update with no impact on trial data or user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.